Acelrx Pharmaceuticals Inc

deal

$ACRX so they make a deal (give away the drug for nothing)and don’t have the BBB alls to do a cc to explain.

Main risks would be continued delays or underwhelming deal for DSUVIA, lack of US Army orders, and any delays/setbacks to EUA for NIYAD.

SHIT COMPANY MANAGEMENT  TELLING STORIES ABOUT PARTNERSHIP AND LICENSE DEAL SINCE 2018, BUT NOTHING MATERIALIZED.

NO PARTNERSHIP LICENSING DEALS, SHIT COMPANY MANAGEMENT KEEPS ON TELLING STORIES SINCE 2018.

By them pushing the deal so far back it hints to me that they don’t truly plan to make any money next year as there is no concern for saving money on taxes, either that or there is no upfront or it’s minuscule

But of course, they were silent about the details of such deal.

revenue

Terrible management 
No execution of good drug revenue plan and we all lost our all money here
I lost most here too
I will never invest in bio or drug related stock which requires FDA approval 
All scam and fraud mostly
90% bio.

SHIT COMPANY MANAGEMENT KEEPS ON TELLING STORIES ABOUT PARTNERSHIP SINCE 2018 TILL TO DATE NOTHING MATERIALIZED AND NO REVENUE.

Negative REVENUE (not sure how you do that) reported this morning.

Spending more than revenue is not financial results it&#39;s lack of financial results.

but bad managment you would think with such a good drug they could have done better but vince felt the need to keep paying him and his team ridiculous weekly salarys without any revenues to cover sorry acrx my funds will no longer be kept here.

PFS-01 &amp; 02          
-  &quot;exceeds $100 million&quot;          
-  &quot;Perioperative medication errors.

patient

-  Frequent blood draws to measure calcium  
are time-consuming and expensive 
-   Even more complicated in patients with liver failure

$ACRX  Sad for Lupus patients, which is very painful too!

The flow rates used to clear waste products and remove fluid from the patient are very fast, potentially putting stress on a patient’s heart and blood pressure.

-  Even more complicated in patients with liver failure    
    
Heparin    
-  Significant safety concern for patients at risk of bleeding.

-  Even more complicated in patients with liver failure 
 
Heparin 
-  Significant safety concern for patients at risk of bleeding 
-  Clinicians fear over anticoagulating the patient 
-  Etc.

Prognosis for patients with ARDS is generally poor and varies based on the severity of illness, the precipitating insult, and medical comorbidities.

Any ideas what’s holding them up on saving their clients money and providing their patients the best in class anesthesia?

executive

I fail to find the right words to describe how pathetic this guy is. CEO?

$ACRX 
So I guess HC Wainwright’s has taken the role of CFO and Rafi has taken the role of CEO…..  WTF is goin’ on over there?!

$ACRX 
Never thought that I will lose all my money here
CEO CFO should deserve to be fire

$ACRX  
 
12/29/23 - 3rd Qtr ER  
 
&quot;Vincent Angotti: Thank you, Raffi.

And we are just thrilled to move this forward and really help these patients out, hopefully with that EUA

And we are just thrilled to move this forward and really help these patients out, hopefully with that EUA.

Niydad might be a tasty accretive buy, with EUA likely in 2023, etc.

And we are just thrilled to move this forward and really help these patients out, hopefully with that EUA (Emergency Use Authorization).

quot

Just MAZIMIZE shareholder value, so do it right! &quot;.

$ACRX The FDA will be pleased with AcelRx &quot;growing database supporting the benefits of DSUVIA-DZUVEO!

&quot;We&#39;re excited to now have DZUVEO as part of our product portfolio available to our existing customers.

product

$ACRX AcelRx has some GREAT EMA &amp; FDA approved products, and I like the potential of Niyad!

$ACRX Battlefield Pain Management 
Our new products meet these requirements and add to the pain-treatment options available to care providers.

It allows doctors to give patients the fluids, nutrition, antibiotics and other medications they need without worrying about the accumulation of waste products and fluid from the failing kidneys.

$ACRX here, let me sum it all up:  Dsuvia=great idea, and a good product.

The slow and continuous nature of the process, typically performed over a 24-hour period, allows patients with unstable blood pressure and heart rates, which is termed hemodynamically unstable, to better tolerate this process.

Ocugen Inc

rate

Strange responses for a company with such high turnover rate and ranked #1 place to work at?

next big news: heart attack rates highest ever in march 2023, courtesy of crap admin

OCGN IS on a cash burn rate countdown to zero and no longer has ANY CREDIBILITY with the investment industry.

Ocgn is on cash burn rate countdown to zero. Duh.

Currently 3 cents above 52 week low, on cash burn rate countdown to zero or more Dilution, the dumbest meme stock failure in the history of meme stocks, attracts paid pumpers to tell you that the sky is the limit !!!

The rate of borrowing is f&#39;king ridiculous.

Literally the turnover rate is higher then fast food industry.

interest

Fake news or hype: Scammers may use fake news or hype to generate interest in their stock.

They’ll NEVER make it as traders bc they have no interest in learning and developing their craft.

$OCGN  and still you are here..with no interest whatsover. pathetic

$OCGN Short interest declining steadily since April..

but think they would be perfect for the fda- pretending to have our best interest at heart but just corrupt to the core.

They have no vested interest here ….APPARENTLY!!!!

$OCGN Or muppets with apparently no interest !!!

demoncrats

$OCGN This market is garbage.. Ty Biden voters..

Powell and that other worthless moron sleepy Joe are destroying this company one day at a time.

$OCGN Fck Biden that scum 🪣 bucket is the worst president in history!

$OCGN $ZOM Joe Biden literally the worst think to happen to America since my birth, holy shit.

$OCGN fuck Shankar, fuck Ocugen, fuck FDA, fuck Biden that is all.

Thanks Joe Biden you absolute fucking waste of a president.

Because the Democrats do not care about the middle

Biden&#39;s obviously corrupt and complicit media covering it up.

Nothing about her putting her seal of approval on any OCGN product.

Here you see a paid basher trying to spread misinformation, originating from the vaccine manufacturers themselves, to try to discredit the product our company is developing.

$OCGN OCGN pipeline consists of unwanted, mediocre at best, not financially viable products.

But there is not enough product that&#39;s its a big old NOTHING BURGER terms of sales.

There is no manufacturing or product lot release without a Quality a team.

Nothing says a tech transfer needs a fda approved product that’s beyond idiotic.

Big pharma is evil - our eye, knee, gene modifier products are a threat their evil as well.

Again they failed to bring this product to market and are so late its laughable.

fear

There only joy is fear and literally getting enjoyment of bothering others -like mosquitos - it’s really sad and a mental issue

Fear, and manipulation thrown to neophyte readers.

$OCGN  This poster is bashing and engaged in hate mongering without providing any substantive analysis or documentary evidence to support hisr allegations.

Go Ocufamily-style on ‘er 
Absolutely Bullish ™️

$OCGN ER is on Tuesday, I’m excited for it.

We get government funding- we execute atm funding - NeoCart phase 3 trials and EuA for nasal vaccine for Usa Europe and japan - I feel extra bullish after AstraZeneca fails nasal vaccine trials.

$OCGN  nice liking the price today okiee https://www.reddit.com/r/shortsqueeze2023/comments/11t3p7v/what_to_expect_for_ocgn_must_read/?utm_source=share&amp;utm_medium=ios_app&amp;utm_name=iossmf

$OCGN OCGN  &amp; PLSH  on cannabinoid research and now the stocks  almost the same share price what a golden opportunity go Ocu400

$OCGN LA is an easy flight for me &amp; my job is remote.

Please may I have some more !!!!!! https://giphy.com/gifs/D3OdaKTGlpTBC?utm_source=media-link&amp;utm_medium=landing&amp;utm_campaign=Media%20Links&amp;utm_term=

$ADXN as a successful former business owner and successful investor, I think that after this company tripling and now expecting epilepsy news, they are 1000% bullish they are going to going to the next phase with Johnson &amp; Johnson.

😎🍺😎
ABSOLUTELY BULLISH™️ https://twitter.com/healthbyjames/status/1620023652069810176?s=12&amp;t=s4vxK6BaKwF7YpJGclvpAg

bullish

$OCGN as scouser would say ABSOLUTELY BULLISH 😎

$OCGN bullish, what to expect moving forward for ocgn https://www.reddit.com/r/shortsqueeze2023/comments/11ntw73/what_to_expect_for_ocgn_going_into_marchapril_of/

sign

$OCGN I like the silence, usually a good sign

Sign up today and start receiving expert insights on potential market opportunities 
 
📈FREE trade-of-week via(Google Search) :⟶  𝐟𝐫𝐞𝐞𝐚𝐥𝐞𝐫𝐭.𝐩𝐰

Steady and strong, it charges ahead, 
A sign of growth and prosperity, no need to be misled.

First Wave BioPharma Inc

china

$FWBI report these Chinese pump and dumpers they do this shit every day.

$FWBI don&#39;t fall for these Chinese bitches pump and dump scams.

report

$FWBI @Sammi_Sweetheart  is a scam report them if you aren’t too busy.

flipper

$FWBI 
Damn this thing can&#39;t gain and hold a 10 cent bump on FDA news and other biotech penny stocks have been pumped as much as 1000% on jack shit.

Any offering usually in pennies, these drop 30-40%.

$FWBI this crap is trading below 3 Pennies pre reverse splits.

$FWBI it’s called “penny land pump trap”

This company has failed products, and is not worth more than 2 pennies

They will be gone in a few pennies and leaving you holding heavy bags!! !

Sapirstien hasn’t produced a SHRED of evidence to prove any of his scam products work.

Their products don’t work, not affective.

Holy Shit, this company(companies) haven’t had one successfull product come out of PHASE 2 trial!!

not one successfull product since its conception of AZRX, and 2 huge reverse splits.

filing

Even screenshots from sec filings are apparently lied to them.

Says they are lies when they are screenshots of sec filings.

$FWBI wrong, here is the minimum float clearly stated in their sec filings

Float : 2M (until it reaches to $1.74) 
Utilization : 100%
Borrow fee : 200%
SI : 25%
Available to borrow : 0
ER : so good 
Upcoming news : phase 2 clinical trial

We will fk shorts so good

$CEAD gonna buy some after I make gains above  👆 before ER

And even better news is that its now fully enrolled Phase 2 oral niclosamide and adrulipase trials could lead to earning a EUA sooner than many think.

We alerted the BUY signal at $4.06 and we were able to close this one with profit at $3.7 🥳

Today $FWBI shows BUY signal (TA) for short term.

$FWBI curling up for a run.. buy and hold..

$FWBI After Tuesday run, i will be go up from there and will be in compliane.. most of the biotech catching momentum and rallying 
 
this is nano floater so will go parabolic nice buy in .. 
 
PT $2-$3 on Tuesday .. holding all my shares ***

bull

$NUZE is about to breakout of this beautiful bull flag formation 
 
Set to rip higher than ever.

coupled with the low float, and margin math in favor of bulls, I believe the anticipation will force this higher.

Glad bulls banking 👊🏼

$EJH got bought up some eod.

$FWBI get ready for pre-market bull run Tuesday 🔥🔥🔥 load enough

$FWBI Ok just sold my quick short position, back to being a bull

$FWBI we had over 2 years of bearish market, now is time to bull&#39;s vengeance.

potential

$LMFA Trending on all platforms with major upside ahead.

$NVOS rounding bottom

 $ZVSA strong potential here 

 $FWBI amazing after hours movement 

 $GOVX goes up everyday.

$FWBI how can you not be bullish on this amazing company with so much potential which has a buy rating and a target price of $4 -🔥🔥🔥💰💰💰

Potential for partnerships and acquisitions.

$FWBI and $goss both have a lot of upward potential in short time imo

$FWBI Can&#39;t wait for Tuesday &gt;  High upside potential 
 
$ARDX  $KALA   $GNPX  👀

Top Stocks matching your search for "er eua"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

ACRX

Acelrx Pharmaceuticals Inc

-66.25%

$2.03 - $0.69

Jan, 15, 2023

OCGN

Ocugen Inc

-23.15%

$1.24 - $0.95

Jan, 14, 2023

Dec, 28, 2022

FWBI

First Wave BioPharma Inc

-29.91%

$4.58 - $3.21

Nov, 16, 2022

Oct, 28, 2022

ACRX

Acelrx Pharmaceuticals Inc

-66.25%

$2.03 - $0.69

Jan, 15, 2023

OCGN

Ocugen Inc

-23.15%

$1.24 - $0.95

Jan, 14, 2023

Dec, 28, 2022

Nov, 6, 2022

FWBI

First Wave BioPharma Inc

-29.91%

$4.58 - $3.21

Nov, 16, 2022

Oct, 28, 2022

Oct, 28, 2022